- Home
- MCRB vs NDLS Comparison
MCRB vs NDLS Comparison
Compare MCRB & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MCRB | NDLS |
|---|---|---|
| Founded | 2010 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.0M | 68.7M |
| IPO Year | 2015 | 2013 |
Fundamental Metrics
Financial Performance| Metric | MCRB | NDLS |
|---|---|---|
| Price | $4.65 | $15.94 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 97.6K | 47.1K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $789,000.00 | ★ $495,089,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 0.37 |
| 52 Week Low | $4.59 | $0.47 |
| 52 Week High | $29.98 | $16.65 |
Technical Indicators
Market Signals| Indicator | MCRB | NDLS |
|---|---|---|
| Relative Strength Index (RSI) | 29.94 | 62.79 |
| Support Level | N/A | $10.71 |
| Resistance Level | $9.53 | $16.10 |
| Average True Range (ATR) | 0.45 | 1.02 |
| MACD | -0.08 | 0.37 |
| Stochastic Oscillator | 7.31 | 81.60 |
Price Performance
Historical ComparisonAbout MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services. It is focused on offering customers flavorful, cooked-to-order dishes in a warm and welcoming environment at an attractive value. It has approximately 340 company-owned restaurants and 83 franchise restaurants in 31 states.